Imitrex Nasal (Sumatriptan Succinate Nasal) - Summary

IMITREX NASAL SUMMARY

IMITREX (sumatriptan) Nasal Spray contains sumatriptan, a selective 5-hydroxytryptamine₁ receptor subtype agonist.

IMITREX Nasal Spray is indicated for the acute treatment of migraine attacks with or without aura in adults.

IMITREX Nasal Spray is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine (see CONTRAINDICATIONS). Safety and effectiveness of IMITREX Nasal Spray have not been established for cluster headache, which is present in an older, predominantly male population.

IMITREX NASAL NEWS HIGHLIGHTS

Media Articles Related to Imitrex Nasal (Sumatriptan)

NovaDel Announces Data From Pilot Efficacy Study Comparing Sumatriptan Oral Spray To Imitrex(R) Tablets
Source: Headache / Migraine News From Medical News Today [2008.09.06]

Zogenix Announces Clinical Study Results For Sumatriptan DosePro™, A Novel Migraine Treatment
Source: Headache / Migraine News From Medical News Today [2008.06.30]

more>>

Published Studies Related to Imitrex Nasal (Sumatriptan)

Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine. [2008.07.08]

Activation of the cortical pain network by soft tactile stimulation after injection of sumatriptan. [2007.12.15]

Sumatriptan for prevention of acute mountain sickness: randomized clinical trial. [2007.09]

Sumatriptan for prevention of acute mountain sickness: Randomized clinical trial. [2007.06.07]

Two double-blind, multicenter, randomized, placebo-controlled, single-dose studies of sumatriptan/naproxen sodium in the acute treatment of migraine: function, productivity, and satisfaction outcomes. [2007.06.07]

more>>

Clinical Trials Related to Imitrex Nasal (Sumatriptan)

Food Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg [Completed]

Fasting Study of Sumatriptan Succinate Tablets 100 mg to Imitrex® Tablets 100 mg [Completed]

Prochlorperazine vs Imitrex for Acute Migraine in the Emergency Department [Completed]

A Study to Evaluate the Pharmacokinetics and Bioequivalence of Sumatriptan Delivered Via the Intraject System [Completed]

Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex® [Completed]

more>>